The Latest Cardiac and Vascular News
EDEN PRAIRIE, Minn., Aug. 19, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the pricing of an underwritten public offering of units for […]
EDEN PRAIRIE, Minn., Aug. 04, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the second quarter ended June 30, 2020, which included the following highlights: Revenue for the second quarter ended June 30, 2020, […]
EDEN PRAIRIE, Minn., July 30, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with SysteMedic Ltd., covering Israel and Palestine, representing the second distribution partnership in the Middle East region. Ultrafiltration therapy […]
EDEN PRAIRIE, Minn., July 08, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) and RenalSense, Ltd., today announced the signing of a distribution agreement to offer complementary solutions for fluid management. The agreement allows CHF Solutions to market and sell RenalSense’s Clarity RMS™ […]
EDEN PRAIRIE, Minn., June 25, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced the promotion of Nestor Jaramillo, Jr. to President and Chief […]
EDEN PRAIRIE, Minn., May 28, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with Transimed Medical Equipment Co. LLC covering the United Arab Emirates, the first distribution partnership in the Middle East […]
EDEN PRAIRIE, Minn., May 12, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2020, which included the following highlights: Revenue for the first quarter ended March 31, 2020, […]
EDEN PRAIRIE, Minn., April 23, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped the first commercial orders of its […]
EDEN PRAIRIE, Minn., April 02, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that it has doubled the production staff that builds its next […]
EDEN PRAIRIE, Minn., March 19, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the Aquadex FlexFlow system has been licensed and approved for sale in India, making ultrafiltration therapy available for patients suffering from hypervolemia, or fluid overload, […]
![Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis](https://cardiacvascularnews.com/wp-content/uploads/2025/01/Life-molecular-imaging-e1737489511884-90x60.png)